The malignancies that were firstassociated with Bcl-2 overexpression were Chronic Lymphocytic Leukemia (CLL) and B-cell Lymphoma, hence the name Bcl-2 (B-cell leukemia/lymphoma-2 protein) [8]. This evidence concerns the gene BCL2 and B-cell non-Hodgkin lymphoma.